List of Quviviq drug patents

Quviviq is owned by Idorsia.

Quviviq contains Daridorexant Hydrochloride.

Quviviq has a total of 3 drug patents out of which 0 drug patents have expired.

Quviviq was authorised for market use on 07 April, 2022.

Quviviq is available in tablet;oral dosage forms.

Quviviq can be used as treatment of insomnia.

Drug patent challenges can be filed against Quviviq from 2026-04-07.

The generics of Quviviq are possible to be released after 02 December, 2034.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9732075 IDORSIA Benzimidazole-proline derivatives
Jun, 2033

(10 years from now)

US9790208 IDORSIA Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
Dec, 2034

(11 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10023560 IDORSIA Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
Dec, 2034

(11 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Apr 7, 2027

Drugs and Companies using DARIDOREXANT HYDROCHLORIDE ingredient

NCE-1 date: 2026-04-07

Market Authorisation Date: 07 April, 2022

Treatment: Treatment of insomnia

Dosage: TABLET;ORAL

More Information on Dosage

QUVIVIQ family patents

7

United States

4

Korea, Republic of

4

European Union

IB

3

IB

3

Lithuania

3

Hungary

3

Singapore

3

Taiwan, Province of China

EA

3

EA

2

Israel

2

South Africa

2

Denmark

2

Mexico

2

Australia

2

Hong Kong

2

Slovenia

2

Morocco

2

Philippines

2

Norway

2

Croatia

2

Portugal

2

Cyprus

2

Malaysia

2

Spain

2

Poland

2

Chile

2

China

2

Ukraine

2

Japan

2

Canada

2

New Zealand

1

Saudi Arabia

1

Argentina

1

Brazil

1

Netherlands

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in